ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors - Wikidata - wikimedia - TriplyDB

ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors

ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors

http://www.wikidata.org/entity/Q33603746

about

Effects of intense pulsed light on tissue vascularity and wound healing: a study with mouse island skin flap model The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis.Emerging Roles of ADAMTSs in Angiogenesis and Cancer.The roles of ADAMTS in angiogenesis and cancer.Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis.miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis

P2860

Q21284505-84F6906A-E6DE-4E5A-B227-910C9A40F3B2 Q27687896-EA286777-D343-4A4F-8F9B-1A3A240CA9F1 Q30384833-7E8DF39C-F591-4A85-8939-78F5274F0B03 Q34294283-C82068E1-A5C3-439B-B5F5-C35CAD9B74DB Q35441108-C209A5F5-9818-431A-AF12-1C474782DF53 Q37017089-A4CAC76E-58E3-4162-8C79-D39D199674A1 Q38444312-CCFE668D-1EE6-43F4-8678-7C3AAD08F3FA Q39150817-D10849E9-B6AB-46F5-B0B0-DF6534DAA8C9 Q41610199-E166CE3E-6D7E-41A3-881D-06DED29DA923 Q58552367-B8FC8972-4B13-4DAA-94BA-93C9385F311A

P2860

ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors

http://www.wikidata.org/entity/Q33603746

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@ast

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@en

type

label

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@ast

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@en

prefLabel

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@ast

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@en

P1433

Q33603746-4DAE8794-7684-477E-BB2C-494F0C710FB6

P1476

Q33603746-ACC262AD-5D6E-4D3E-8EA0-7DAE486E0F59

P2093

Q33603746-3A793C51-F4D6-463E-927F-4D976A1AC999

Q33603746-3CCE8822-99AB-4147-B0DF-4AD4966D6A6D

Q33603746-47D2C32E-CE0A-42AF-88CB-2D6B08C56EF8

Q33603746-59C729E1-439C-4D66-8A8C-786B944747E8

Q33603746-79A0F944-BDDF-448E-A306-D129D26CB42A

Q33603746-F103CF38-D666-435A-A6F7-F48F89880797

P2860

Q33603746-1AF7D240-D4BB-430A-8D04-900E238586E4

Q33603746-207F515B-D1F0-42CD-8A8A-65CB20B26E8E

Q33603746-222A99E8-8F3A-48BE-9296-247D584D71A1

Q33603746-25F6DC46-65F0-4764-A42B-0C89DCEF8C4D

Q33603746-4F443054-21DE-43E8-B5F1-8D7069E0FD4B

Q33603746-5A72B2AD-5CD1-4A22-BB1C-393F4E0F4C1B

Q33603746-63702EBA-1CCA-4652-BF38-7181C8CA9D05

Q33603746-6647F389-550C-4518-8BE9-610A7644DF19

Q33603746-68847A2C-721B-4F97-80EB-50CA8CBD501F

Q33603746-78088D7E-6CB5-4691-BAA7-0015C30862B8

P2888

Q33603746-32AD83AB-B68D-4100-A26A-AB3960B9CD64

P304

Q33603746-9ED3A27A-C40D-417B-A52E-BF754A014F1B

P31

Q33603746-C126DB4B-5A33-4C59-A3C5-AB88F2945F94

P356

Q33603746-61BABEF4-FACA-485F-B3BA-9CF18FEAA434

P407

Q33603746-97E7E5F1-5AA5-4213-A91A-A2CB1C754241

P478

Q33603746-5BDA6624-E29F-4B32-8B65-F62AC3E8491E

P577

Q33603746-793F7993-E014-41E9-B2DD-914F777BECE7

P5875

Q33603746-188C7B8F-3127-40F7-826E-AF0164B23C1C

P6179

Q33603746-4E525A3D-0B84-447B-87DD-3F85BA0DD020

P698

Q33603746-9C33A737-2D88-49A7-91D0-53DDB3DE5BA9

P932

Q33603746-1642AC8C-0B2D-49A8-A8F2-894787E5CA5A

P356

1471-2407-10-288

P1433

P1476

ADAMTS1 alters blood vessel mo ...... P and LNCaP-19 prostate tumors

@en

P2093

Heléne Gustavsson

http://www.w3.org/2001/XMLSchema#string

Jan-Erik Damber

http://www.w3.org/2001/XMLSchema#string

Karin Jennbacken

http://www.w3.org/2001/XMLSchema#string

Karin Welén

http://www.w3.org/2001/XMLSchema#string

Kouji Kuno

http://www.w3.org/2001/XMLSchema#string

Tajana Tesan

http://www.w3.org/2001/XMLSchema#string

P2860

METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity

Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene

U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.

Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation

ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.

Mechanisms of normal and tumor-derived angiogenesis.

ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2

ADAMTS1: a matrix metalloprotease with angioinhibitory properties.

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

P2888

1471-2407-10-288

P304

288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-288

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44671823

http://www.w3.org/2001/XMLSchema#string

P6179

1028397338

http://www.w3.org/2001/XMLSchema#string

P698

20546609

http://www.w3.org/2001/XMLSchema#string

P932

2894797

http://www.w3.org/2001/XMLSchema#string